Mitochondrial Dysfunction and Its Relationship with mTOR Signaling and Oxidative Damage in Autism Spectrum Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|15|5|373-389

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.15, Iss.5, 2015-08, pp. : 373-389

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Thematic Issue: Mitochondrial Dysfunction and Its Relation to Translocator Protein, Oxidative Stress, mTOR Signaling, and Synaptic Protein)

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 5, 2015-08 ,pp. : 353-354

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR, a Potential Target to Treat Autism Spectrum Disorder

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 5, 2016-05 ,pp. : 533-543

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting mTOR Signaling Pathway in Ovarian Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 19, 2011-06 ,pp. : 2960-2968

Bentham Science Publishers

Access to resources Recommend Favorite

The mTOR Signaling Network: Insights from Its Role During Embryonic Development

By  

Current Medicinal Chemistry, Vol. 15, Iss. 12, 2008-05 ,pp. : 1192-1208

Bentham Science Publishers

Access to resources Recommend Favorite

Immune-Glutamatergic Dysfunction as a Central Mechanism of the Autism Spectrum Disorders

By  

Current Medicinal Chemistry, Vol. 16, Iss. 2, 2009-01 ,pp. : 157-170

Bentham Science Publishers

Access to resources Recommend Favorite